Last week on the Buzz, I shared a link from a Q&A with Dr. Marcia Angell, former editor of the New England Journal of Medicine. If you are an investor in the biotech or pharma space and didn't take time to read it, print it out and read it on the plane to the Minyanfest. If Senator Kerry wins, I would not be surprised if Dr. Angell is first in line for the FDA Commissioner spot. Even if she isn't, expect the views expressed in her Q&A to be very influential on the direction of the FDA in a Kerry administration.
Hot political rumor: John McCain will be nominated as the GOP VP at the end of this month. Yeah, old rumor but this is the first time we've heard it from McCain operatives in Arizona.
Toddo, where I grew up it was "ass over tea kettle." Unless the tea "cup" better describes cranial capacity than a tea "kettle."
Biotechs are strong enough in the last two sessions to make people think about their "sitting on the hands" approach. I note the NASDAQ Biotech Index has been up three or more days in a row only nine times this year - and nearly all either were in the first two months or happened during window dressing times at the end of a month.
There are so many places to go with this headline, I don't know where to start. At least Cassini isn't orbiting one planet farther out...
If you haven't seen it yet, here is the list of guinea pig stocks in the SEC's grand experiment to determine the effect of altered short-sale rules.
If you sell the house you grew up in, don't go back and see what the new owners are doing to it.
There are redemptions and then there are redemptions.
Do you merchandise these next to the bulk junk food, baby supplies, exercise equipment, or what?
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter